2seventy bio, Inc. (TSVT) Reports Q3 Loss, Lags Revenue Estimates
Portfolio Pulse from
2seventy bio, Inc. (TSVT) reported a Q3 loss of $0.18 per share, missing the Zacks Consensus Estimate of a $0.14 loss. This is an improvement from a $1 per share loss a year ago.
November 12, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
2seventy bio, Inc. reported a Q3 loss of $0.18 per share, which was worse than the expected loss of $0.14 per share. Despite this, the loss is an improvement from the previous year's $1 per share.
The company's reported loss was worse than expected, which is typically negative for stock prices. However, the improvement from last year's loss may mitigate some negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100